Click here to download Javelin's Annual Report for 2008
News:
June 23, 2009 Javelin Pharmaceuticals Completes Open Label Safety Study of Dyloject™ June 15, 2009 New Study Shows Javelin Pharmaceutical's DylojectTM Well-Tolerated in High-Risk Patients with Impaired Renal and Hepatic Function
May 7, 2009 Javelin Pharmaceuticals, Inc. Reports First Quarter 2009 Results and Corporate Highlights Click here for the webcast (Registration Required)
May 4, 2009 Javelin Pharmaceuticals to Announce First Quarter 2009 Financial Results
March 12, 2009 Javelin Pharmaceuticals Reports Fiscal Results for the Year Ended 2008 Click here for the webcast (Registration Required)
March 5, 2009 Javelin Pharmaceuticals Quarterly Conference Call Invitation
CONTACT US JOIN US SITE MAP © 2005-2009 Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.
Read
more 
